Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Devonian Health Group Inc V.GSD

Alternate Symbol(s):  DVHGF

Healthcare Biotechnology
Devonian Health Group Inc. is a clinical-stage pharmaceutical company. It specializes in the development of drugs for various autoimmune inflammatory conditions with novel therapeutic approaches to targeting unmet medical needs. It is developing prescription drugs for the treatment of inflammatory autoimmune diseases, including but not limited to, ulcerative colitis and atopic dermatitis. It is also involved in the development of cosmeceutical products, leveraging the same proprietary approach employed with their pharmaceutical offerings. Its flagship product, Thykamine, is a pharmaceutical product issued from its SUPREX platform, for the prevention and treatment of health problems related to inflammation and oxidative stress, including ulcerative colitis, atopic dermatitis, psoriasis, rheumatoid arthritis, and other autoimmune diseases. Its cosmeceutical products include R-Spinasome and Purgenesis. Its subsidiary, Altius Healthcare Inc., sells prescription pharmaceutical products.


TSXV:GSD - Post by User

Devonian Health Group Inc
<< Previous
 Bullboard Posts
User Avatar Image
(1656)
•••
  • Possibleidiot01X
Post by Possibleidiot01on Mar 05, 2025 9:28am
86 Views
Post# 36479927

fund manager Martin Mathieu comment

fund manager Martin Mathieu comment

  • Devonian Health Group (TSX-V: GSD), a clinical-stage healthcare company with a revenue-generating pharmaceutical distribution business, announced the loss of its largest customer. The terminated distribution agreement represented 92% of the revenue in its last quarter and over $15 million in its previous fiscal year. What I like most is the timing of the release: the good old Friday night!



<< Previous
 Bullboard Posts
Dealroom for high-potential pre-IPO opportunities